This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Plan your wardrobe costs with a simple calculator to separate essentials from trends, so you don’t overspend and still look great every season.
6,795 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
As SpaceX eyes the public markets, investors buzz about a potential IPO rush and a comeback for stock-split enthusias...
A fresh analysis finds the study: bipartisan social security plan to borrow and invest funds would leave taxpayers wi...
Nvidia is poised to report fiscal Q1 2027 results as traders assess whether it can sustain a 75% gross margin amid re...
A U.S. mortgage lender scrapped its first AI platform after weak adoption and replaced it with an integrated system t...
As investors parse Nano-X Imaging's Q4 2025 results, this guide breaks down the numbers, the business model, and what...
Retirees should anchor planning on cash flow rather than asset size. Here is how the math stacks up in today's market...
Quantum dreams meet market drama as Rigetti and peers grab headlines. This guide breaks down why rigetti computing st...
Markets extended their rally into a eight-week stretch, with the S&P 500 and Dow hitting fresh highs. This piece brea...
AI's rise depends not only on chips and servers but on the cooling and mechanical systems that keep data centers aliv...